Trials / Sponsors / Sichuan Huiyang Life Science and Technology Corporation
Sichuan Huiyang Life Science and Technology Corporation
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19 COVID-19, SARS-CoV-2 Infection | Phase 2 | 2022-07-01 |
| Terminated | Study of rSIFN-co for Patients With Advanced Solid Tumors Malignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor | Phase 1 | 2016-01-01 |
| Completed | A Study of rSIFN-co in Subjects With Advanced Solid Tumors Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma | Phase 1 | 2013-07-01 |